person · Reporting owner
KOSECOFF JACQUELINE B
Disclosed activity across 8 companies
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Alignment Healthcare, Inc.ALHC · Entity 4269 | Director | March 13, 2026 | March 17, 2026 |
| GoodRx Holdings, Inc.GDRX · Entity 4838 | Director | December 31, 2022 | February 13, 2023 |
| HOULIHAN LOKEY, INC.HLI · Entity 3553 | Director | May 22, 2025 | May 23, 2025 |
| SEALED AIR CORP/DESEE · Entity 53140 | Director | May 21, 2020 | May 22, 2020 |
| STERIS plcSTE · Entity 3228 | Director | August 08, 2024 | August 12, 2024 |
| TRINET GROUP, INC.TNET · Entity 4202 | Director | May 28, 2026 | June 01, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Alignment Healthcare, Inc.
Report date March 13, 2026 · Filed March 17, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 303,963 |
Reported balance
After 2026-03-13 transaction · row 1
1 source rowRow 1 · 2026-03-13 · Grant · Acquired 13,096 · Balance 303,963 F1: Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents 13,096 restricted stock units, each restricted stock unit representing a right to receive one share of Common Stock of the Company, all of which will vest on the one-year anniversary of the grant date unless the reporting person ceases to serve as a member of the Board of Directors prior to such date.
GoodRx Holdings, Inc.
Report date December 31, 2022 · Filed February 13, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 27,440 |
Reported balance
After 2022-08-17 transaction · row 1
1 source rowRow 1 · 2022-08-17 · Gift · Disposed 6,138 · Balance 27,440 F1: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries. |
| Class A Common StockSEC Table I · non-derivative | IndirectBy Trust | 6,138 |
Reported balance
After 2022-08-17 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2022-08-17 · Gift · Acquired 6,138 · Balance 6,138 F1: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries. |
Filing footnotes · ownership attribution and instrument terms
F1: On August 17, 2022, the Reporting Person transferred 6,138 shares of Class A common stock to the Robert H. Brook and Jacqueline B. Kosecoff Family Trust, of which the Reporting Person and her spouse serve as trustees and are the sole beneficiaries.
HOULIHAN LOKEY, INC.
Report date May 22, 2025 · Filed May 23, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CLASS A COMMON STOCKSEC Table I · non-derivative | Direct | 15,316 |
Reported balance
After 2025-05-22 transaction · row 1
1 source rowRow 1 · 2025-05-22 · Grant · Acquired 563 · Balance 15,316 |
SEALED AIR CORP/DE
Report date May 21, 2020 · Filed May 22, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,167 |
Reported balance
After 2020-05-21 transaction · row 1
1 source rowRow 1 · 2020-05-21 · Grant · Acquired 4,167 · Balance 4,167 F1: Award made under the 2014 Omnibus Incentive Plan. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 40,937 |
Reported balance
Holding disclosure · report date 2020-05-21 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 40,937 F2: Shares held indirectly in a trust for the benefit of Dr. Kosecoff and her husband. |
| Stock UnitsSEC Table II · derivative / convertible security | Direct | 8,744 |
Reported balance
Holding disclosure · report date 2020-05-21 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 8,744 F3: 1-for-1 F4: The units are to be settled in shares of Common Stock (with certain exceptions specified in the Corporation's Deferred Compensation Plan for Directors) following the reporting person's retirement from the Board of Directors. F5: Reflects the addition of units converted from dividend equivalents. |
Filing footnotes · ownership attribution and instrument terms
F1: Award made under the 2014 Omnibus Incentive Plan.
F2: Shares held indirectly in a trust for the benefit of Dr. Kosecoff and her husband.
F3: 1-for-1
F4: The units are to be settled in shares of Common Stock (with certain exceptions specified in the Corporation's Deferred Compensation Plan for Directors) following the reporting person's retirement from the Board of Directors.
F5: Reflects the addition of units converted from dividend equivalents.
STERIS plc
Report date August 08, 2024 · Filed August 12, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $239.68 · Expires 2034-08-08 | Direct | 1,388 |
Reported balance
After 2024-08-08 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2024-08-08 · Grant · Acquired 1,388 · Balance 1,388 F1: These nonqualified stock options are fully vested and are exercisable immediately. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,546 |
Reported balance
After 2024-08-08 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2024-08-08 · Grant · Acquired 494 · Balance 6,546 F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 6,988 |
Reported balance
After 2024-08-08 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2024-08-08 · Grant · Acquired 442 · Balance 6,988 F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F4: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $106,000 . F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. |
Filing footnotes · ownership attribution and instrument terms
F1: These nonqualified stock options are fully vested and are exercisable immediately.
F2: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service.
F3: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service.
F4: These Career Restricted Stock Units were issued to the Reporting Person in lieu of fees of $106,000 .
TRINET GROUP, INC.
Report date May 28, 2026 · Filed June 01, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 4,735 |
Last balance in matching sequence
After 2026-05-29 transaction · row 2
Source-order balances reconcile. Account continuity and personal attribution are not independently verified.
2 source rowsRow 1 · 2026-05-28 · Grant · Acquired 4,735 · Balance 7,384 F1: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the earlier of the 12-month anniversary of the date of grant and the trading day preceding the date of the Company's 2027 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events. F2: The total securities beneficially owned includes shares of unvested restricted stock units. Row 2 · 2026-05-29 · Gift · Disposed 2,649 · Balance 4,735 F3: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F2: The total securities beneficially owned includes shares of unvested restricted stock units. |
| Common StockSEC Table I · non-derivative | IndirectBy Trust | 17,007 |
Reported balance
After 2026-05-29 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2026-05-29 · Gift · Acquired 2,649 · Balance 17,007 F3: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust. F4: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects the grant of Restricted Stock Units that convert into Common Stock, par value $0.000025 per share, of the Issuer, on a one-for-one basis. The Restricted Stock Units will vest 100% on the earlier of the 12-month anniversary of the date of grant and the trading day preceding the date of the Company's 2027 Annual Meeting of the Stockholders, subject to the director's continued service. The Restricted Stock Units are also subject to accelerated vesting upon certain events.
F2: The total securities beneficially owned includes shares of unvested restricted stock units.
F3: Represents a transfer of shares to a trust, of which the reporting person and her spouse are trustees and beneficiaries of the trust.
F4: Shares held directly by the Robert H. Brook and Jacqueline B. Kosecoff Family Trust (the "Trust"). The Reporting Person and her spouse serve as trustees and beneficiaries of the Trust.
Past disclosures · reporting ended (2)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ATHENAHEALTH INC
Report date February 11, 2019 · Filed February 13, 2019
Section 16 reporting ended · disclosed 2019-02-13. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2019-02-11 transaction · row 1
1 source rowRow 1 · 2019-02-11 · Disposition to issuer · Disposed 12,806 · Balance 0 F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes. F2: 1,931 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration. |
Filing footnotes · ownership attribution and instrument terms
F1: Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes.
F2: 1,931 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration.
STERIS plc
Report date March 28, 2019 · Filed March 28, 2019
Section 16 reporting ended · disclosed 2019-03-28. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Ordinary Shares, 10 pence par valueSEC Table I · non-derivative | IndirectSee Footnote Below | 0 |
Reported balance
After 2019-03-28 transaction · row 1
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 1 · 2019-03-28 · Disposition to issuer · Disposed 42,830 · Balance 0 F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. 1,260 shares that had been directly held were transferred to the trust on November 23, 2018. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $28.08 · Expires 2019-07-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2019-03-28 · Disposition to issuer · Disposed 3,609 · Balance 0 F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,609 ordinary shares of STERIS for $28.08 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.34 · Expires 2020-08-04 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · 2019-03-28 · Disposition to issuer · Disposed 3,133 · Balance 0 F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $31.61 · Expires 2021-08-03 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2019-03-28 · Disposition to issuer · Disposed 3,121 · Balance 0 F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.36 · Expires 2022-08-03 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2019-03-28 · Disposition to issuer · Disposed 3,218 · Balance 0 F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $43.92 · Expires 2023-08-08 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2019-03-28 · Disposition to issuer · Disposed 4,657 · Balance 0 F7: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,657 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $51.53 · Expires 2024-08-06 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2019-03-28 · Disposition to issuer · Disposed 4,584 · Balance 0 F8: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,584 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $64.05 · Expires 2025-08-31 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2019-03-28 · Disposition to issuer · Disposed 4,110 · Balance 0 F9: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $71.40 · Expires 2026-08-10 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2019-03-28 · Disposition to issuer · Disposed 3,781 · Balance 0 F10: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $86.23 · Expires 2027-08-09 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2019-03-28 · Disposition to issuer · Disposed 927 · Balance 0 F11: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Director Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $114.74 · Expires 2028-08-09 | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2019-03-28 · Disposition to issuer · Disposed 436 · Balance 0 F12: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. |
| Career Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2019-03-28 transaction · row 12
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 12 · 2019-03-28 · Disposition to issuer · Disposed 3,184 · Balance 0 F13: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS.
F2: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. 1,260 shares that had been directly held were transferred to the trust on November 23, 2018.
F3: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,609 ordinary shares of STERIS for $28.08 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F4: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F5: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F6: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F7: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,657 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F8: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,584 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F9: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F10: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F11: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F12: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option.
F13: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 3,133 | Not disclosed Strike: $32.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,133 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 F4 · price: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. F4 · derivative.exercise_date: This option to purchase 3,133 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,133 Old STERIS ordinary shares for $32.34 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC | STERIS plc STE · Entity 3228 | GrantDirector Stock Option (right to buy) · Derivative | 3,609 | Not disclosed Strike: $28.08 | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,609 Underlying: Ordinary Shares · 3,609 shares Expires 2019-07-31 F3 · price: This option to purchase 3,609 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,609 Old STERIS ordinary shares for $28.08 per share, subject to the same terms and conditions as the original Old STERIS stock option. F3 · derivative.exercise_date: This option to purchase 3,609 STERIS ordinary shares, which is fully vested, was received under the Scheme in exchange for an option to purchase 3,609 Old STERIS ordinary shares for $28.08 per share, subject to the same terms and conditions as the original Old STERIS stock option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 19:30 UTC | STERIS plc STE · Entity 3228 | GrantOrdinary Shares | 42,830 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021603 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 42,830 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS") received by the reporting person pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received shares of STERIS in an amount equal to the number of the reporting person's cancelled shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"). The reporting person's STERIS shares are subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2 · ownership.nature: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerCareer Restricted Stock Units · Derivative | 3,184 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 12 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,184 shares Expires not disclosed F13 · derivative.exercise_price: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F13 · derivative.exercise_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. F13 · derivative.expiration_date: These career restricted stock units were assumed by STERIS pursuant to the Scheme and converted to career restricted stock units of STERIS representing the right to receive 3,184 STERIS ordinary shares. These career restricted stock units are fully vested and will be settled in STERIS ordinary shares six months after the cessation of the reporting person's board service, subject to the terms and conditions of the award agreement. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 436 | Not disclosed Strike: $114.74 | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 11 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F12 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F12 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 436 ordinary shares of STERIS for $114.74 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 927 | Not disclosed Strike: $86.23 | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 10 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 927 shares Expires 2027-08-09 F11 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F11 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 927 ordinary shares of STERIS for $86.23 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 3,781 | Not disclosed Strike: $71.40 | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 9 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,781 shares Expires 2026-08-10 F10 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F10 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,781 ordinary shares of STERIS for $71.40 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 4,110 | Not disclosed Strike: $64.05 | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 8 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,110 shares Expires 2025-08-31 F9 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F9 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,110 ordinary shares of STERIS for $64.05 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 4,584 | Not disclosed Strike: $51.53 | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 7 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,584 shares Expires 2024-08-06 F8 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,584 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F8 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,584 ordinary shares of STERIS for $51.53 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 4,657 | Not disclosed Strike: $43.92 | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 6 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,657 shares Expires 2023-08-08 F7 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,657 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F7 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 4,657 ordinary shares of STERIS for $43.92 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 3,218 | Not disclosed Strike: $32.36 | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 5 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,218 shares Expires 2022-08-03 F6 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F6 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,218 ordinary shares of STERIS for $32.36 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 3,121 | Not disclosed Strike: $31.61 | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,121 shares Expires 2021-08-03 F5 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F5 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,121 ordinary shares of STERIS for $31.61 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 3,133 | Not disclosed Strike: $32.34 | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,133 shares Expires 2020-08-04 F4 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F4 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,133 ordinary shares of STERIS for $32.34 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerDirector Stock Option (right to buy) · Derivative | 3,609 | Not disclosed Strike: $28.08 | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,609 shares Expires 2019-07-31 F3 · price: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,609 ordinary shares of STERIS for $28.08 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. F3 · derivative.exercise_date: This option is fully vested. This option was assumed by STERIS under the Scheme and converted to an option to purchase 3,609 ordinary shares of STERIS for $28.08 per share, subject to the same terms and conditions that were applicable to the original Old STERIS option. Read SEC document |
| March 28, 2019 Filed Mar 28, 2019 13:55 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 10 pence par value | 42,830 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-19-021561 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below Disclosed balance after: 0 F1 · price: Represents ordinary shares of STERIS plc, a public limited company organized under the laws of England and Wales ("Old STERIS"), cancelled pursuant to a court-approved scheme of arrangement under English law (the "Scheme"). In connection with the Scheme, the reporting person received ordinary shares of STERIS plc, a public limited company organized under the laws of Ireland ("STERIS"), in an amount equal to the number of the reporting person's cancelled Old STERIS shares. The reporting person's STERIS shares will be subject to terms and conditions, including restrictions, substantially identical to those that were applicable to the Old STERIS shares. Following the completion of the Scheme, STERIS became the ultimate holding company of Old STERIS. F2 · ownership.nature: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. 1,260 shares that had been directly held were transferred to the trust on November 23, 2018. Read SEC document |
| February 11, 2019 Filed Feb 13, 2019 18:30 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | Disposition to issuerCommon Stock | 12,806 | $135.00 | $1,728,810.00 |
DisclosureSEC source: 0001131096-19-000036 · wf-form4_155010062019920.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Pursuant to the terms of the Agreement and Plan of Merger, dated as of November 11, 2018, among athenahealth, Inc. (the "Company"), May Holding Corp., and May Merger Sub Inc. (the "Merger Agreement"), on February 11, 2019, each share of athenahealth common stock, par value $0.01 ("Common Stock") issued and outstanding immediately prior to the Effective Time (as defined in the Merger Agreement) and not otherwise excluded pursuant to the terms of the Merger Agreement, was converted into the right to receive $135.00 per share in cash (the "Merger Consideration"), subject to any required withholding taxes. F2 · shares: 1,931 of these securities represent shares of Common Stock underlying athenahealth restricted stock unit ("RSU") awards subject to time-based vesting. Pursuant to the Merger Agreement, on February 11, 2019, unvested RSUs outstanding immediately prior to the Effective Time were canceled and converted into the right to receive the Merger Consideration. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 20:22 UTC | STERIS plc STE · Entity 158792 | GrantCareer Restricted Stock Units · Derivative | 108 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046225 · doc4.xml · derivative · entry 5 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,184 Underlying: Ordinary Shares · 108 shares Expires not disclosed F4 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F5 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F5 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 20:22 UTC | STERIS plc STE · Entity 158792 | GrantDirector Stock Option (right to buy) · Derivative | 436 | $0.00 Strike: $114.74 | $0.00 |
DisclosureSEC source: 0001209191-18-046225 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436 Underlying: Ordinary Shares · 436 shares Expires 2028-08-09 F3 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 20:22 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 265 | $114.74 | $30,406.10 |
DisclosureSEC source: 0001209191-18-046225 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,260 F1 · shares: Represents the number of ordinary shares withheld to satisfy taxes. Read SEC document |
| August 09, 2018 Filed Aug 10, 2018 20:22 UTC | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 1,525 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-046225 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,525 Read SEC document |
| June 06, 2018 Filed Jun 8, 2018 18:26 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | GrantCommon Stock | 1,931 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-18-000152 · wf-form4_152849674399890.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,806 F1 · shares: Represents an award of restricted stock units ("RSUs") under the Issuer's 2007 Stock Option and Incentive Plan, as amended and restated (the "2007 Plan"), granted pursuant to the Issuer's 2018 Director Compensation Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs fully vest on June 6, 2019. F2 · balance_after: Includes 1,931 units of common stock that were granted pursuant to RSU awards under the 2007 Plan. The RSUs are subject to time-based vesting and will be settled only in stock. Read SEC document |
| May 17, 2018 Filed May 18, 2018 15:46 UTC | SEALED AIR CORP/DE SEE · Entity 53140 | GrantCommon Stock | 2,640 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-18-018035 · form4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,319 F1 · price: Award made under the 2014 Omnibus Incentive Plan. Read SEC document |
| April 30, 2018 Filed Jun 13, 2018 20:18 UTC | HOULIHAN LOKEY, INC. HLI · Entity 3553 | GrantCLASS A COMMON STOCK | 1,404 | $0.00 | $0.00 |
DisclosureSEC source: 0001302215-18-000019 · wf-form4_152892107097974.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,446 Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 21:25 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 2,744 | $0.00 Strike: $34.17 | $0.00 |
DisclosureSEC source: 0001209191-18-015028 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,744 shares Expires 2018-07-31 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: This option to purchase 2,744 STERIS plc ordinary shares, which is fully vested, was received in conjunction with the "Combination" of STERIS Corporation and Synergy Health, Ltd. in exchange for an option to purchase 2,744 STERIS Corporation common shares for $34.17 per share, subject to the same terms and conditions as the original STERIS Corporation stock option. Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 21:25 UTC | STERIS plc STE · Entity 158792 | SaleOrdinary Shares, 10 pence par value | 2,744 | $91.94 | $252,283.36 |
DisclosureSEC source: 0001209191-18-015028 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · price: Price reflects a weighted average sale price for multiple transactions ranging from $91.80 to $92.15 per share, inclusive. The Reporting Person undertakes to provide, upon request by the SEC Staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each separate price Read SEC document |
| February 28, 2018 Filed Mar 1, 2018 21:25 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 10 pence par value | 2,744 | $34.17 | $93,762.48 |
DisclosureSEC source: 0001209191-18-015028 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,744 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| October 02, 2017 Filed Oct 3, 2017 20:50 UTC | STERIS plc STE · Entity 158792 | Tax withholdingOrdinary Shares, 10 pence par value | 335 | $88.80 | $29,748.00 |
DisclosureSEC source: 0001209191-17-055197 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,230 F1 · shares: Withholding for 1,565 Ordinary Shares issued on October 2, 2017. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 20:29 UTC | STERIS plc STE · Entity 158792 | GrantCareer Restricted Stock Units · Derivative | 1,014 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-048599 · doc4.xml · derivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,859 Underlying: Ordinary Shares · 1,014 shares Expires not disclosed F2 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS ordinary share six months after the cessation of the Director's Board service. F3 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. F3 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS ordinary shares six months after the cessation of the Director's Board service. Read SEC document |
| August 09, 2017 Filed Aug 11, 2017 20:29 UTC | STERIS plc STE · Entity 158792 | GrantDirector Stock Option (right to buy) · Derivative | 4,058 | $0.00 Strike: $86.23 | $0.00 |
DisclosureSEC source: 0001209191-17-048599 · doc4.xml · derivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,058 Underlying: Ordinary Shares · 4,058 shares Expires 2027-08-09 F1 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. Read SEC document |
| August 09, 2017 Filed Oct 3, 2017 20:48 UTC Amendment | STERIS plc STE · Entity 158792 | GrantCareer Restricted Stock Units · Derivative | 231 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-055190 · doc4a.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 231 Underlying: Ordinary Shares · 231 shares Expires not disclosed F5 · derivative.exercise_price: Each Career Restricted Stock Unit represents the right to receive one STERIS Ordinary Share six months after the cessation of the Director's Board service. F6 · shares: The amount of Career Restricted Stock Units awarded was overstated on the Reporting Person's original Form 4. This Form 4/A reflects the correct amount F7 · derivative.exercise_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS Ordinary Shares six months after the cessation of the Director's Board service. F7 · derivative.expiration_date: These Career Restricted Stock Units are fully vested immediately. They will be settled in STERIS Ordinary Shares six months after the cessation of the Director's Board service. F6 · derivative.underlying_shares: The amount of Career Restricted Stock Units awarded was overstated on the Reporting Person's original Form 4. This Form 4/A reflects the correct amount F6 · balance_after: The amount of Career Restricted Stock Units awarded was overstated on the Reporting Person's original Form 4. This Form 4/A reflects the correct amount Read SEC document |
| August 09, 2017 Filed Oct 3, 2017 20:48 UTC Amendment | STERIS plc STE · Entity 158792 | GrantDirector Stock Option (right to buy) · Derivative | 927 | $0.00 Strike: $86.23 | $0.00 |
DisclosureSEC source: 0001209191-17-055190 · doc4a.xml · derivative · entry 3 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 927 Underlying: Ordinary Shares · 927 shares Expires 2027-08-09 F3 · shares: The amount of options awarded was overstated on the Reporting Person's original Form 4. This Form 4/A reflects the correct amount. F4 · derivative.exercise_date: These nonqualified stock options are fully vested and are exercisable immediately. F3 · derivative.underlying_shares: The amount of options awarded was overstated on the Reporting Person's original Form 4. This Form 4/A reflects the correct amount. F3 · balance_after: The amount of options awarded was overstated on the Reporting Person's original Form 4. This Form 4/A reflects the correct amount. Read SEC document |
| August 09, 2017 Filed Oct 3, 2017 20:48 UTC Amendment | STERIS plc STE · Entity 158792 | GrantOrdinary Shares, 10 pence par value | 1,565 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-055190 · doc4a.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,565 F1 · shares: The Reporting Person's original Form 4 omitted the grant of these Ordinary Shares. This Form 4/A reflects the correct amount. F1 · balance_after: The Reporting Person's original Form 4 omitted the grant of these Ordinary Shares. This Form 4/A reflects the correct amount. Read SEC document |
| May 18, 2017 Filed May 19, 2017 18:42 UTC | SEALED AIR CORP/DE SEE · Entity 53140 | GrantCommon Stock | 2,679 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-17-018788 · form4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,679 F1 · price: Award made under the 2014 Omnibus Incentive Plan. Read SEC document |
| April 30, 2017 Filed May 2, 2017 18:11 UTC | HOULIHAN LOKEY, INC. HLI · Entity 3553 | GrantCLASS A COMMON STOCK | 1,863 | $0.00 | $0.00 |
DisclosureSEC source: 0001302215-17-000012 · wf-form4_149374869360081.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,042 Read SEC document |
| March 01, 2017 Filed Mar 3, 2017 16:35 UTC | ATHENAHEALTH INC ATHN · Entity 160326 | GrantCommon Stock | 1,896 | $0.00 | $0.00 |
DisclosureSEC source: 0001131096-17-000022 · wf-form4_148857692045474.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,875 F1 · shares: Represents an award of restricted stock units ("RSUs") under the Issuer's 2007 Stock Option and Incentive Plan, as amended and restated, granted pursuant to the Issuer's 2017 Director Compensation Plan. Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSUs fully vest on March 1, 2018. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:36 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionDirector Stock Option (right to buy) · Derivative | 3,387 | $0.00 Strike: $27.68 | $0.00 |
DisclosureSEC source: 0001209191-17-015893 · doc4.xml · derivative · entry 4 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,387 shares Expires 2017-07-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These nonqualified stock options are fully vested and were exercisable immediately upon grant. Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:36 UTC | STERIS plc STE · Entity 158792 | Disposition to issuerOrdinary Shares, 0.10 par value | 3,387 | $70.45 | $238,597.22 |
DisclosureSEC source: 0001209191-17-015893 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Read SEC document |
| February 27, 2017 Filed Mar 1, 2017 21:36 UTC | STERIS plc STE · Entity 158792 | Exercise / conversionOrdinary Shares, 0.10 par value | 3,387 | $27.68 | $93,752.16 |
DisclosureSEC source: 0001209191-17-015893 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,387 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:36 UTC | STERIS plc STE · Entity 158792 | GiftOrdinary Shares, 0.10 par value | 21,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-014366 · doc4.xml · nonDerivative · entry 2 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Below. Disclosed balance after: 30,302 F1 · ownership.nature: These ordinary shares are held in a revocable family trust of the Reporting Person and the Reporting Person's spouse, as Co-Trustees. Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 21:36 UTC | STERIS plc STE · Entity 158792 | GiftOrdinary Shares, 0.10 par value | 21,239 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-014366 · doc4.xml · nonDerivative · entry 1 KOSECOFF JACQUELINE B · CIK 0001209524 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,038 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.